Unilateral axillary Adenopathy in the setting of COVID-19 vaccine

With the recent U.S. Food and Drug Administration (FDA)-approval and rollout of the Pfizer-BioNTech and Moderna COVID-19 vaccines, it is important for radiologists to consider recent COVID-19 vaccination history as a possible differential diagnosis for patients with unilateral axillary adenopathy. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehta, Nishi, Sales, Rachel Marcus, Babagbemi, Kemi, Levy, Allison D., McGrath, Anika L., Drotman, Michele, Dodelzon, Katerina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2021
Materias:
Breast Imaging
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817408/
https://www.ncbi.nlm.nih.gov/pubmed/33486146
http://dx.doi.org/10.1016/j.clinimag.2021.01.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817408/
https://www.ncbi.nlm.nih.gov/pubmed/33486146
http://dx.doi.org/10.1016/j.clinimag.2021.01.016

Ejemplares similares